tiprankstipranks
Catheter Precision (VTAK)
XASE:VTAK
US Market
VTAK
Catheter Precision
RESEARCH TOOLSreports
Want to see VTAK full AI Analyst Report?

Catheter Precision (VTAK) Ratios

489 Followers

Catheter Precision Ratios

VTAK's free cash flow for Q4 2025 was $0.92. For the 2025 fiscal year, VTAK's free cash flow was decreased by $ and operating cash flow was $-25.13. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Mar 24Dec 22
Liquidity Ratios
Current Ratio
 0.10 0.10 1.58 1.68 2.22
Quick Ratio
 0.08 0.08 1.56 1.67 2.22
Cash Ratio
 0.02 0.02 1.38 1.44 2.09
Solvency Ratio
 -1.63 -1.64 -0.91 -7.18 -3.49
Operating Cash Flow Ratio
 -2.12 -2.12 -4.45 -8.34 -2.98
Short-Term Operating Cash Flow Coverage
 -12.43 -12.44 -52.38 -112.06 0.00
Net Current Asset Value
$ -8.82M$ -8.82M$ -12.72M$ -5.38M$ 9.26M
Leverage Ratios
Debt-to-Assets Ratio
 0.24 0.24 0.06 0.01 0.00
Debt-to-Equity Ratio
 0.55 0.55 0.15 0.02 0.00
Debt-to-Capital Ratio
 0.35 0.35 0.13 0.02 0.00
Long-Term Debt-to-Capital Ratio
 0.31 0.31 0.11 0.00 0.00
Financial Leverage Ratio
 2.25 2.25 2.36 1.45 1.82
Debt Service Coverage Ratio
 -16.14 -16.14 -53.89 -82.12 0.00
Interest Coverage Ratio
 -50.35 -43.35 -123.55 0.00 0.00
Debt to Market Cap
 3.82 <0.01 0.06 <0.01 0.00
Interest Debt Per Share
 <0.01 <0.01 0.58 0.07 0.00
Net Debt to EBITDA
 -0.22 -0.22 0.10 0.21 0.71
Profitability Margins
Gross Profit Margin
27.84%92.31%90.00%93.21%-1050.00%
EBIT Margin
-2347.25%-2347.25%-3193.10%-3888.01%-162778.57%
EBITDA Margin
-2089.01%-2089.01%-2690.95%-3418.55%-159771.43%
Operating Profit Margin
-1727.47%-1487.30%-2676.90%-17673.98%-192578.57%
Pretax Profit Margin
-2381.56%-2381.56%-3214.76%-15966.52%-191871.43%
Net Profit Margin
-2086.69%-2098.05%-3962.62%-15966.52%-191892.86%
Continuous Operations Profit Margin
-2160.56%-2160.56%-3962.62%-15966.52%-191892.86%
Net Income Per EBT
87.62%88.10%123.26%100.00%100.01%
EBT Per EBIT
137.86%160.13%120.09%90.34%99.63%
Return on Assets (ROA)
-107.76%-108.34%-59.93%-229.61%-159.57%
Return on Equity (ROE)
-239.52%-243.59%-141.56%-333.00%-290.12%
Return on Capital Employed (ROCE)
-118.36%-101.91%-43.77%-276.39%-291.16%
Return on Invested Capital (ROIC)
-101.70%-87.56%-43.31%-273.73%-291.16%
Return on Tangible Assets
-2738.78%-2753.69%-476.06%-1597.37%-159.57%
Earnings Yield
-1.68%-0.87%-59.51%-16.73%-2.32%
Efficiency Ratios
Receivables Turnover
 5.28 5.28 6.00 3.23 0.00
Payables Turnover
 0.40 0.04 0.18 0.06 1.75
Inventory Turnover
 6.87 0.73 1.27 0.68 0.00
Fixed Asset Turnover
 3.62 3.62 2.14 1.78 0.00
Asset Turnover
 0.05 0.05 0.02 0.01 <0.01
Working Capital Turnover Ratio
 -0.26 -0.71 0.29 0.08 <0.01
Cash Conversion Cycle
 -799.26 -8.08K -1.65K -5.00K -208.57
Days of Sales Outstanding
 69.08 69.08 60.83 113.13 0.00
Days of Inventory Outstanding
 53.11 498.25 286.79 535.33 0.00
Days of Payables Outstanding
 921.46 8.64K 2.00K 5.65K 208.57
Operating Cycle
 122.19 567.33 347.62 648.47 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 -2.84 -3.75 -21.83
Free Cash Flow Per Share
 >-0.01 >-0.01 -2.86 -3.77 -21.84
CapEx Per Share
 <0.01 <0.01 0.02 0.01 0.02
Free Cash Flow to Operating Cash Flow
 1.01 1.00 1.01 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -78.94 -488.00 -138.37 -271.30 -1.33K
Capital Expenditure Coverage Ratio
 -78.94 -488.00 -138.37 -271.30 -1.33K
Operating Cash Flow Coverage Ratio
 -2.16 -2.16 -5.19 -55.43 0.00
Operating Cash Flow to Sales Ratio
 -10.12 -10.13 -22.07 -46.65 -1.61K
Free Cash Flow Yield
-826.47%-0.42%-33.39%-4.91%-1.95%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -58.98 -115.09 -1.68 -5.98 -43.07
Price-to-Sales (P/S) Ratio
 1.23 2.41K 66.59 954.30 82.65K
Price-to-Book (P/B) Ratio
 142.90 280.34 2.38 19.90 124.96
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.12 -237.88 -3.00 -20.38 -51.24
Price-to-Operating Cash Flow Ratio
 -121.61 -238.37 -3.02 -20.46 -51.27
Price-to-Earnings Growth (PEG) Ratio
 3.03 -0.83 0.03 0.12 0.48
Price-to-Fair Value
 142.90 280.34 2.38 19.90 124.96
Enterprise Value Multiple
 -0.28 -115.80 -2.38 -27.70 -51.02
Enterprise Value
 4.77M 1.98B 26.88M 418.61M 1.14B
EV to EBITDA
 -0.28 -115.80 -2.38 -27.70 -51.02
EV to Sales
 5.83 2.42K 64.01 947.08 81.52K
EV to Free Cash Flow
 -0.57 -238.34 -2.88 -20.23 -50.53
EV to Operating Cash Flow
 -0.58 -238.82 -2.90 -20.30 -50.57
Tangible Book Value Per Share
 >-0.01 >-0.01 -3.84 -0.93 8.96
Shareholders’ Equity Per Share
 <0.01 <0.01 3.60 3.86 8.96
Tax and Other Ratios
Effective Tax Rate
 0.09 0.09 -0.23 0.00 >-0.01
Revenue Per Share
 <0.01 <0.01 0.13 0.08 0.01
Net Income Per Share
 -0.02 -0.02 -5.10 -12.84 -25.98
Tax Burden
 0.88 0.88 1.23 1.00 1.00
Interest Burden
 1.01 1.01 1.01 4.11 1.18
Research & Development to Revenue
 3.45 1.05 0.65 1.07 456.57
SG&A to Revenue
 14.10 14.74 27.02 0.00 0.00
Stock-Based Compensation to Revenue
 0.33 0.41 0.13 2.75 31.93
Income Quality
 0.47 0.48 0.56 0.29 0.84
Currency in USD